This website provides general educational information and does not replace professional medical advice, diagnosis, or treatment. Medical guidance and research findings may change. Consult qualified healthcare professionals for individual health concerns.
What Are Vaccines?
A vaccine is a biological product that prepares the immune system to recognize and respond to a specific pathogen—a virus, bacterium or toxin—before a person is exposed to it naturally. Rather than treating an illness after it begins, most vaccines are preventive: they create immune memory so that a future encounter is met with a faster, stronger defense.
Vaccines do this by presenting the immune system with an antigen, a molecular feature that identifies the pathogen. Depending on the vaccine, the antigen may be delivered as a weakened or inactivated organism, a purified protein, an inactivated toxin, or genetic instructions that allow the body’s own cells to produce the antigen temporarily.
- Term
- Antigen
- Any substance the immune system can recognize as foreign. In vaccines, antigens are chosen because an immune response against them can help protect against the target pathogen.
Understanding the Immune System
The immune system has two broad, interconnected branches. The innate immune system responds within minutes to hours. It recognizes general patterns associated with microbes, triggers inflammation and alerts other immune cells. It does not, however, form specific long-term memory.
The adaptive immune system is slower to respond the first time but highly specific. Its key players are:
- B cells, which can mature into plasma cells that produce antibodies—proteins that bind to antigens and can neutralize pathogens or mark them for destruction.
- Helper T cells (CD4+), which coordinate the immune response and help B cells produce effective antibodies.
- Cytotoxic T cells (CD8+), which recognize and destroy infected cells.
- Memory B and T cells, which persist after an immune response and enable a quicker reaction on re-exposure.
How Vaccines Help Build Protection
When a vaccine is given, antigen-presenting cells pick up the antigen and carry it to lymph nodes, where adaptive immune responses are organized. B and T cells that recognize the antigen multiply and specialize. Some vaccines also contain an adjuvant, an ingredient that strengthens or shapes the immune response.
When many people in a community are immune, a pathogen has fewer opportunities to spread. This indirect protection, often called community immunity or herd immunity, can help protect people who cannot be vaccinated or who respond less strongly to vaccines. How much coverage is needed varies by disease and by vaccine.
Types of Vaccine Technologies
| Platform | How it works | Examples |
|---|---|---|
| Live attenuated | Contains a weakened form of the pathogen that can replicate in a limited way. | Measles, mumps and rubella (MMR); varicella |
| Inactivated | Contains pathogens that have been killed and cannot replicate. | Inactivated polio vaccine; hepatitis A |
| Subunit, recombinant and conjugate | Contains selected purified pieces of the pathogen, such as proteins or sugars, sometimes linked to a carrier protein. | Hepatitis B; HPV; pneumococcal conjugate |
| Toxoid | Contains an inactivated toxin so the body learns to neutralize the harmful toxin. | Tetanus; diphtheria |
| Viral vector | Uses a modified, harmless virus to deliver genetic instructions for an antigen. | Some Ebola and COVID-19 vaccines |
| Messenger RNA (mRNA) | Delivers short-lived mRNA instructions so cells produce an antigen; the mRNA does not enter the cell nucleus or alter DNA. | Some COVID-19 and RSV vaccines |
Vaccine Development Stages
- Exploratory and preclinical research
Scientists identify candidate antigens and test them in laboratory systems and animal models for safety and immune response.
- Phase 1 clinical trials
A small number of healthy volunteers receive the candidate to assess safety, tolerability, dose and early immune responses.
- Phase 2 clinical trials
Hundreds of participants help refine dosing and schedules and expand safety information.
- Phase 3 clinical trials
Large studies, often with thousands of participants, test whether the vaccine prevents infection or disease and look for less common side effects.
- Regulatory review and licensure
A regulator—in the United States, the Food and Drug Administration (FDA)—reviews the full data package and manufacturing quality before deciding on approval.
- Post-licensure monitoring
Safety and effectiveness continue to be studied after a vaccine is in widespread use.
Clinical Research and Safety Evaluation
Safety is assessed at every stage. In trials, participants are monitored for expected reactions (such as injection-site pain) and for any adverse events, whether or not they appear related to the vaccine. Independent Data and Safety Monitoring Boards review accumulating results and can recommend pausing or stopping a trial. The Clinical Trial Education page explains these safeguards in more detail.
Understanding Effectiveness and Limitations
Efficacy describes how well a vaccine performs under controlled trial conditions. Effectiveness describes how well it performs in the real world, across more diverse populations and circumstances. Both are usually expressed as a relative reduction in risk compared with unvaccinated people.
No vaccine provides perfect protection for every person. Protection can vary with age, health status, the time since vaccination and changes in the pathogen. Some vaccines are better at preventing severe disease than at preventing any infection at all.
Like all medical products, vaccines can cause side effects. Most are mild and short-lived. Serious adverse reactions are rare, and when they are identified, regulators weigh them against the benefits of vaccination and may update recommendations.
Vaccine Safety Monitoring
Because very rare effects may not appear even in large trials, safety monitoring continues after approval. In the United States, systems include the Vaccine Adverse Event Reporting System (VAERS), co-managed by the CDC and FDA, which accepts reports from anyone; the Vaccine Safety Datalink, which analyzes health records to test whether a possible signal is real; and additional FDA and CDC surveillance programs. A report to VAERS does not by itself mean a vaccine caused the event—it is a signal that can prompt further investigation.
Common Vaccine Misconceptions
- “Natural immunity is always better.” Infection can produce strong immunity, but it carries the risk of the disease itself, including severe illness and complications.
- “mRNA vaccines change your DNA.” mRNA does not enter the cell nucleus, where DNA is kept, and is broken down by the body after it is used.
- “Vaccines cause autism.” Extensive research has found no such link.
- “If a vaccine is not 100% effective, it is useless.” Partial protection can still substantially reduce illness, hospitalization and spread.
Understanding Scientific Evidence
A single study rarely settles a question. Confidence grows when multiple well-designed studies, conducted by different teams in different populations, reach consistent conclusions. Randomized controlled trials, large observational studies and systematic reviews each contribute different kinds of evidence. Our Public Health Literacy guide explains how to weigh them.
Frequently Asked Questions
Can a vaccine give me the disease it protects against?
Vaccines that do not contain live pathogens—such as inactivated, subunit, toxoid, mRNA and most viral-vector vaccines—cannot cause the infection they target. Live attenuated vaccines contain weakened organisms; in healthy people they rarely cause more than mild symptoms, but they are generally not recommended for some people with severely weakened immune systems. A clinician can advise which vaccines are appropriate for an individual.
Why do some vaccines need boosters?
For some vaccines, antibody levels and other immune responses decline over time, or the pathogen changes. A booster dose restimulates immune memory. Influenza vaccines, for example, are updated because circulating flu viruses change from season to season.
Are side effects a sign that a vaccine is working?
Common short-term reactions such as a sore arm, tiredness or a mild fever reflect the immune system responding, but their absence does not mean a vaccine failed. Many people develop good protection with no noticeable reaction.
Do vaccines cause autism?
No. Large studies involving millions of children in several countries have found no link between vaccines and autism. The 1998 paper that started this claim was retracted by The Lancet in 2010 after serious problems with its research were found.
If most people are vaccinated, why can outbreaks still happen?
No vaccine is 100% effective, protection can wane, and outbreaks can spread among groups with lower vaccination coverage. Protection across a community depends on how well a vaccine works and how many people are immune.